William Tracewell - Concepedia

Author

William Tracewell

Also Known As

W Tracewell, W. Tracewell, W.G. Tracewell, WILLIAM G. TRACEWELL, William G Tracewell, William G. Tracewell, William Tracewell

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Teva Pharmaceuticals (United States)Avalon Pharma (United States)PRA Health Sciences Radboud University Medical Center University of Nebraska Medical Center

About

William Tracewell is an author at Teva Pharmaceuticals (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	362
2	Pharmacology	9	9	333
3	Health Sciences	2	2	27
4	Gastroenterology	2	2	139
5	Nephrology	2	2	47

William Tracewell

Publications

748

Citations

H-Index

Page 1

	Year	Citations
Effects of Chlorophyll and Chlorophyllin on Low-Dose Aflatoxin B1 Pharmacokinetics in Human Volunteers Carole Jubert, John E. Mata, Graham Bench, Cancer Prevention Research	2009	118
Absolute and Relative Bioavailability of Fentanyl Buccal Tablet and Oral Transmucosal Fentanyl Citrate Mona Darwish, Mary Kirby, Philmore Robertson, The Journal of Clinical Pharmacology Fentanyl Buccal TabletMedicinal ChemistryPharmaceutical SciencePharmacological StudyMedicine	2007	101
Pharmacokinetics of an Antisense Phosphorothioate Oligodeoxynucleotide against <i>rev</i> from Human Immunodeficiency Virus Type 1 in the Adult Male Rat Following Single Injections and Continuous Infusion Patrick L. Iversen, John A. Mata, William Tracewell, Antisense Research and Development	1994	84
Pharmacokinetic properties of fentanyl effervescent buccal tablets: A phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 μg in healthy adult volunteers Mona Darwish, Mary Kirby, Philmore Robertson, Clinical Therapeutics Healthy Adult VolunteersPharmacological StudyMedicinePharmacotherapyPain Management	2006	45
Population pharmacokinetics of hydroxyurea in cancer patients William Tracewell, Donald L. Trump, William P. Vaughan, Cancer Chemotherapy and Pharmacology OncologyMedicinePharmacotherapyPopulation PharmacokineticsCancer Treatment	1995	43
Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects Frank Schneider, Lavi Erisson, Hooman Beygi, British Journal of Clinical Pharmacology	2018	39
Absorption of Fentanyl from Fentanyl Buccal Tablet in Cancer Patients With or Without Oral Mucositis Mona Darwish, Mary Kirby, Philmore Robertson, Clinical Drug Investigation Fentanyl Buccal TabletMedicineGastrointestinal PharmacologyGastroenterologyClinical Pharmacology	2007	38
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement Michelle Mellion, Lucienne Ronco, Cécile L. Berends, British Journal of Clinical Pharmacology	2021	37
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment Christopher J. Sweeney, Chris H. Takimoto, Leslie Wood, Cancer Chemotherapy and Pharmacology UrologyRenal FunctionMedicineForensic ToxicologySafety Study	2009	32
Bioequivalence Following Buccal and??Sublingual Placement of Fentanyl??Buccal Tablet 400????g in??Healthy Subjects Mona Darwish, Mary Kirby, John Jiang, Clinical Drug Investigation Healthy SubjectsBioequivalencePharmacologySublingual PlacementPharmacotherapy	2007	32

Page 1